older glp 1 drugs GLP-1 Medications Infographic America's Poison Centers - GLP-1

2500 scientists and staff)

Nishita Pattni, senior consultant at Worldpanel by Numerator, said: "Rising adoption in markets like the US, combined with continued innovation, points to even faster uptake

Much of the focus on the impact of GLP-1 receptor agonists (and combination drugs with components that target other receptors such as gastric inhibitory polypeptide collectively termed GLP-1s in this article) to date has been on their potential to improve long-term health outcomes for people with type 2 diabetes, obesity, and related cardiovascular diseases

doi: 10.1186/1471-2415-7-8 9 MimuraLYVillaresSMMonteiroMLGuazzelliICBloiseW

eNeuro 2017

10.1007/s00592-018-1271-3 13